Effectiveness of honey on Staphylococcus aureus and Pseudomonas aeruginosa biofilms

被引:143
作者
Alandejani, Talal
Marsan, Joseph
Ferris, Wendy
Slinger, Robert
Chan, Frank
机构
[1] Univ Ottawa, Dept Otolaryngol, Ottawa, ON, Canada
[2] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada
关键词
CHRONIC RHINOSINUSITIS; BACTERIAL BIOFILMS; ANTIBIOTIC SUSCEPTIBILITIES; ADULTS;
D O I
10.1016/j.otohns.2009.01.005
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
OBJECTIVES: Biofilms formed by Pseudomonas aeruginosa (PA) and Staphylococcus aureus (SA) have been shown to be an important factor in the pathophysiology of chronic rhinosinusitis (CRS). As well, honey has been used as an effective topical antimicrobial agent for years. Our objective is to determine the in vitro effect of honey against biofilms produced by PA and SA. STUDY DESIGN: in vitro testing of honey against bacterial biofilms. METHODS: We used a previously established biofilm model to assess antibacterial activity of honey against 11 methicillin-susceptible SA (MSSA), 11 methicillin-resistant SA (MRSA), and 11 PA isolates. Honeys were tested against both planktonic and biofilm-grown bacteria. RESULTS: Honey was effective in killing 100 percent of the isolates in the planktonic form. The bactericidal rates for the Sidr and Manuka honeys against MSSA, MRSA, and PA biofilms were 63-82 percent, 73-63 percent, and 91-91 percent, respectively. These rates were significantly higher (P < 0.001) than those seen with single antibiotics commonly used against SA. CONCLUSION: Honey, which is a natural, nontoxic, and inexpensive product, is effective in killing SA and PA bacterial biofilms. This intriguing observation may have important clinical implications and could lead to a new approach for treating refractory CRS. (C) 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation. All rights reserved.
引用
收藏
页码:114 / 118
页数:5
相关论文
共 18 条
[1]   Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis [J].
Aaron, SD ;
Ferris, W ;
Ramotar, K ;
Vandemheen, K ;
Chan, F ;
Saginur, R .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (11) :4172-4179
[2]   Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis [J].
Bendouah, Zohra ;
Barbeau, Jean ;
Abou Hamad, Walid ;
Desrosiers, Martin .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2006, 134 (06) :991-996
[3]   Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology [J].
Benninger, MS .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2003, 129 (03) :S1-S32
[4]  
Brudzynski K, 2006, CAN J MICROBIOL, V52, P1228, DOI 10.1139/W06-086
[5]   The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms [J].
Ceri, H ;
Olson, ME ;
Stremick, C ;
Read, RR ;
Morck, D ;
Buret, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) :1771-1776
[6]   Effectiveness of topical antibiotics on Staphylococcus aureus biofilm in vitro [J].
Desrosiers, Martin ;
Bendouah, Zohra ;
Barbeau, Jean .
AMERICAN JOURNAL OF RHINOLOGY, 2007, 21 (02) :149-153
[7]   Methods for removing bacterial biofilms:: In vitro study using clinical chronic rhinosinusitis specimens [J].
Desrosiers, Martin ;
Myntti, Matthew ;
James, Garth .
AMERICAN JOURNAL OF RHINOLOGY, 2007, 21 (05) :527-532
[8]  
Dunford C, 2000, Nurs Stand, V15, P63
[9]  
Lusby P E, 2002, J Wound Ostomy Continence Nurs, V29, P295, DOI 10.1067/mjw.2002.129073
[10]  
Molan P C, 1999, J Wound Care, V8, P415